SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Significant Differences in Drug Lag in Clinical Development Among Various Strategies Used for Regulatory Submissions in Japan
1 references·2 citing·9 second hop
Significant Differences in Drug Lag in Clinical Development Among Various Strategies Used for Regulatory Submissions in Japan (2013)Significant Differences in Drug Lag in Cl…The role of firm characteristics in pharmaceutical product launches (2006)The role of firm characterist…Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis (2020)Evolving Landscape of New Dru…Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan? (2015)Recent trends for drug lag in…Delays in New Drug Applications in Japan and Industrial R&D Strategies (2009)Approval of new drugs 1999-2007: comparison of the US, the EU and Japan situations (2010)MONOPOLISTIC COMPETITION AND OPTIMUM PRODUCT DIVERSITY (1975)Entry and Competition in Concentrated Markets (1991)The Regulation of Entry (2000)Patents, Price Controls, and Access to New Drugs: How Policy Affects Global Market Entry (2005)Entry and Patenting in the Software Industry (2011)Effects of Regulation on Drug Launch and Pricing in Interdependent Markets (2012)Regulatory Review of New Therapeutic Agents — FDA versus EMA, 2011–2015 (2017)
this work references cited by second hop

References

  • 2006The role of firm characteristics in pharmaceutical product launches105 cited

Cited by

  • 2020Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis51 cited
  • 2015Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?50 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work